William Blair Has Pessimistic Outlook of AXSM Q3 Earnings
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) – Stock analysts at William Blair dropped their Q3 2026 earnings estimates for Axsome Therapeutics in a research note issued on Monday, June 9th. William Blair analyst M. Minter now expects that the company will post earnings per share of $0.58 for the quarter, down from their prior […]
